Through your experience in the field you have the unique opportunity to bring
innovative decision support solutions to life, resolving the unmet medical
need of matching drugs with individual tumors as a prerequisite for optimal
treatment outcome in all cancer patients. You will have the meaningful and
rewarding role of supporting and guiding the therapeutic decision making of oncologists across cancer areas, and to lay the foundations for the use of our
support solutions across geographies.

If you are a pioneer, a creative problem solver with a passion for genomics,
digital health and artificial intelligence, if you are driven by an entrepreneurial
mindset, a leader by example and a team player, then you may be the right
candidate we are looking for.

Your responsibilities will include but are not limited to:
1 – Building a commercialization-ready molecular diagnostics laboratory in
Switzerland that can serve as a laboratory model across other countries (EU,
US), including all activities required to achieve accreditation, certification and
reimbursement of our services, and in compliance with the effective
international and country-specific regulations and guidelines for diagnostic
laboratories, medical devices and SaaS.
2- Supporting the building of a laboratory franchise across Europe and North
America.
3- Guiding the team’s direction, maintaining overview of planning, progress,
quality and budget.
4- Supporting the development of SCCD solutions for other cancer entities
and advancing them to commercialization readiness state, in collaboration
with our bioinformatics team and experts in the respective cancer fields
beyond-breast cancer.
5- Driving your team to make OncoGenomX a preferred diagnostics service
provider thanks to agile execution and effective partnering with oncologists,
cancer care practitioners and hospitals.
As the Head of Smart Cancer Co-Diagnostics you will be part of the
OncoGenomX leadership team, reporting to the CEO, with an option of
earning stock options and becoming a partner and/or member of the
founders group.

OncoGenomX is a Swiss venture founded in October 2019. Our mission is to
empower oncologists to choose precisely those drugs that will most
effectively help their patient to achieve durable disease control. This is made
possible by:
1- A gene expression assay to determine the biological properties,
pharmacological sensitivities and clinical behavior of individual tumors.
2- The use of artificial intelligence to determine which cancer drugs are
appropriate for every tumor and which will permanently prevent disease
progression or metastasis.
3- Provision of collective treatment results from comparable patients, who
have completed treatment informed by Smart Cancer Co-Diagnostics (SCCD).
4- A machine learning routine to continuously learn from previous treatment
decisions and therapy results.
The Head of Smart Cancer Co-Diagnostics is an exciting opportunity to set up
our Swiss Smart Cancer Co-Diagnostics Laboratory. (S)he will be responsible
for the organization and management of the laboratory, the formation of a
team and the extension of our support services to cancer types beyond
breast cancer.
At the heart of this opportunity lies the development and validation of gene
expression assays run on nCounter and Illumina instrumentation, their
validation, certification and advancement to commercialization readiness.

Contact: Wolfgang Hackl, Managing Director OncoGenomX.

E-Mail: hacklwo@oncogenomx.com

• Graduate qualification in nursing, life science, dentistry, medical sciences, pharmacy with at least 3-5 years clinical trial monitoring experience.
• Good knowledge of ICH-GCP with some experience in biostatistics, managing clinical trial sites.
• Working knowledge of Swiss/EU regulations for conducting clinical trials.
• Good medical and scientific judgement.
• Ability to evaluate, interpret and present scientific data.
• Self-motivated, able to prioritize and plan effectively.
• Attention to detail.
• Able and willing to travel up to 50%.
• Excellent knowledge of MS Office tools (Word, Excel, Outlook, …).
• Excellent numerical, written and verbal communication skills.
• Fluency in written and verbal English is a must. Good command on German and other languages is preferred.
• Based in North-western Switzerland region.

Your responsibilities will include but are not limited to:

• Organise and manage multicentre clinical trials for investigational drugs/ medical devices/ diagnostic tests in order to make an accurate benefit/ risk analysis.
• In-house and on-site clinical monitoring throughout the duration of the trial (site selection, site initiation/training visits, routine monitoring visits, close out visits).
• Daily interactions with site staff (investigators, research coordinators, study nurses,…) in local language, as well as with internal and external stakeholders.
• Evaluating the quality and integrity of site practices and escalating any quality issues appropriately.
• Support and give guidance to the Clinical Operations team with writing clinical trial protocols, trial manuals, Case Report Forms (CRFs), Data Clarification Forms (DCFs), and other documentation.
• Support logistics with supplying study centres with sufficient quantities of study drugs/equipment etc.
• Training clinical study site staff on how to conduct the trials in accordance with GCP standards.

• Join a small team of multinational, multidisciplinary, highly motivated experts.
• Modern, inclusive, pleasant working environment in a fast-growing, dynamic organization.
• Ability to independently manage your role and responsibilities.
• Opportunity to develop yourself and support start-ups developing highly innovative therapies.
• Office-based employment in Liestal (Switzerland), 7min by foot from Liestal SBB train station.

If you meet the described profile, we look forward to receiving your CV and cover letter in English, including supporting documents, by e-mail to serena.bologna@hemex.ch

We only accept direct applications of qualified candidates. Requests from headhunters and job agencies will not be answered.